Propiedad y actividad de insiders de Silence Therapeutics plc (SLN): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $12.50 |
| Capitalización | $590M |
| Bolsa | NASDAQ |
| País | GB |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $39.0M | $42.7M | $21.5M | $13.5M | $27.4M | $73.5M | $54.8M | $54.4M | $96.9M | $11.3M |
| Inversiones a Corto | 0 | $319000 | $5.0M | $20.0M | $10.0M | 0 | $16.3M | 0 | $20.8M | $73.8M |
| Cuentas por Cobrar | $810000 | $2.0M | $2.4M | $4000 | $29.3M | $331000 | $915000 | $19.0M | $776375 | $24.6M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $42.0M | $45.5M | $29.5M | $37.5M | $76.4M | $86.3M | $96.7M | $81.6M | $149.7M | $118.7M |
| Inmovilizado Material | $1.4M | $1.2M | $921000 | $611000 | $1.1M | $1.9M | $2.2M | $2.3M | $1.6M | $1.7M |
| Fondo de Comercio | $7.7M | $8.0M | $8.1M | $7.7M | $8.1M | $7.6M | $8.0M | $10.0M | $7.5M | $10.6M |
| Activos Intangibles | $45000 | $28000 | $64000 | $34000 | $17000 | $24000 | $320000 | $362000 | $249206 | $288000 |
| Activos Totales | $55.8M | $55.0M | $38.9M | $46.1M | $86.0M | $96.2M | $107.5M | $94.5M | $161.9M | $131.4M |
| Cuentas por Pagar | $528000 | $462000 | $1.1M | $1.8M | $2.3M | $4.1M | $3.2M | $2.6M | $3.0M | $4.4M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.6M | $2.7M | $3.8M | $9.7M | $25.6M | $15.2M | $21.9M | $17.7M | $13.4M | $13.6M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.6M | $2.7M | $3.8M | $25.2M | $76.9M | $87.7M | $85.4M | $77.1M | $54.8M | $69.1M |
| Reservas | -$116.0M | -$116.4M | -$133.8M | -$152.0M | -$184.2M | -$223.0M | -$263.3M | -$431.9M | -$378.6M | -$562.6M |
| Patrimonio Neto | $54.2M | $52.4M | $35.1M | $20.9M | $9.1M | $8.5M | $22.1M | $22.0M | $107.0M | $62.3M |
| Deuda Total | 0 | 0 | 0 | $287000 | $341000 | $137000 | $446000 | $273808 | $93452 | $160000 |
| Deuda Neta | -$39.0M | -$43.1M | -$26.5M | -$33.2M | -$37.1M | -$73.4M | -$70.7M | -$54.2M | -$117.6M | -$85.0M |
| Capital Circulante | $40.4M | $42.9M | $25.7M | $27.8M | $50.8M | $71.2M | $74.7M | $64.0M | $136.2M | $105.0M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 7.42 |
Rentabilidad
| Rentabilidad sobre capital | -106.94% |
| Rentabilidad sobre capital invertido | -71.25% |
| Rentabilidad sobre activos | -56.34% |
| Margen bruto | 51.00% |
| Margen operativo | -10880.25% |
| Margen neto | -9759.23% |
Empresas relacionadas: ACIU · ALDX · AMRN · ANRO · CAPR · CTNM · KYTX
Explorar sector: Healthcare · Biotechnology
Más secciones de SLN: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones